Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Long-term finasteride use doesn't change bone density or metabolism.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

A person with Turner Syndrome showed severe schizophrenia that didn't respond to treatment and had brain shrinkage.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Family-based treatment is the best outpatient care for stable teens with anorexia, and more research is needed on medication and treatment effectiveness for young people with eating disorders.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Finasteride effectively stops hair loss in most patients, but concerns about rare sexual side effects exist.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Topical minoxidil 1% and 2% are twice as effective as placebo for female pattern hair loss.

Hair problems can be caused by genetics or the environment, and treatment should focus on the cause and reducing hair damage.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Estrogens and progesterone are key in regulating melasma pigmentation.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.